Mettler-Toledo International, Inc.

MTD Healthcare Diagnostics & Research

Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.

1,622.29 16.75 −1.02%
Market cap
$32.8B
P/E
36.4×
Fwd P/E
25.5×
Dividend yield
—
F-score
5/9
Altman Z
10.23
Beneish M
−2.44
Dividend safety
n/a

Mettler-Toledo International, Inc. (MTD) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Mettler-Toledo International, Inc. (MTD) trades at a EV/EBITDA of 26.6×. Over the past ten years it has ranged from 14.8× (October 2015) to 37.9× (December 2021); the current reading is higher than 74% of that period. That is above the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 24.8× 10.92%
FY2024 22.3× (6.02%)
FY2023 23.8× (15.37%)
FY2022 28.1× (24.17%)
FY2021 37.0× 14.87%
FY2020 32.2× 28.04%
FY2019 25.2× 27.85%
FY2018 19.7× (20.20%)
FY2017 24.7× 25.29%
FY2016 19.7× 12.70%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 21.3× (3.86%)
Mar 2026 22.1× (10.68%)
Dec 2025 24.8× 11.76%
Sep 2025 22.2× 2.28%
42 more quarters

Against its own ten years

Low 14.8× High 37.9×
Ten-year median 23.8×
Current reading's percentile 74

EV/EBITDA against peers

Company EV/EBITDA
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.5×
IQV IQVIA Holdings Inc. compare 17.1×
A Agilent Technologies, Inc. compare 26.5×
MTD Mettler-Toledo International, Inc. 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MTD